Last week we introduced you to ORTHO Regenerative Technologies, a  cutting-edge med tech firm that uses its proprietary RESTORE technology  platform to dramatically improve the success rate of orthopedic and  sports medicine surgeries.

• In layman’s terms, that means company has a wonder delivery  platform that delivers biologics – drugs made from biological processes –  to repair soft tissues in the human body.

Now the firm has appointed Patrick O’Donnell to its board of directors.

• O’Donnell comes with significant company-building experience
• He will prove crucial in putting this healthcare pioneer on-track for a NASDAQ listing

Claude LeDuc, Ortho’s CEO, breaks down the appointment: